A double-blind, randomized, placebo-controlled trial of once-daily venlafaxine extended release (XR) and fluoxetine for the treatment of depression
- 1 December 1999
- journal article
- clinical trial
- Published by Elsevier in Journal of Affective Disorders
- Vol. 56 (2-3) , 171-181
- https://doi.org/10.1016/s0165-0327(99)00067-1
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Efficacy and Tolerability of Once-Daily Venlafaxine Extended Release (XR) in Outpatients With Major DepressionThe Journal of Clinical Psychiatry, 1997
- Once-Daily Venlafaxine Extended Release (XR) and Venlafaxine Immediate Release (IR) in Outpatients with Major DepressionAnnals of Clinical Psychiatry, 1997
- Bioavailability of once-daily venlafaxine extended release compared with the immediate-release formulation in healthy adult volunteersCurrent Therapeutic Research, 1997
- Are Two Antidepressant Mechanisms Better Than One?The Journal of Clinical Psychiatry, 1997
- A double-blind comparison of venlafaxine and fluoxetine for treatment of major depression in outpatientsProgress in Neuro-Psychopharmacology and Biological Psychiatry, 1996
- A double-blind comparison of venlafaxine and fluoxetine in patients hospitalized for major depression and melancholiaInternational Clinical Psychopharmacology, 1994
- Analysis of the Hamilton Depression Rating Scale factors from a double-blind, placebo-controlled trial of fluoxetine in geriatric major depressionInternational Clinical Psychopharmacology, 1993
- Paroxetine: A selective serotonin reuptake inhibitor showing better tolerance, but weaker antidepressant effect than clomipramine in a controlled multicenter studyJournal of Affective Disorders, 1990
- A New Depression Scale Designed to be Sensitive to ChangeThe British Journal of Psychiatry, 1979
- A RATING SCALE FOR DEPRESSIONJournal of Neurology, Neurosurgery & Psychiatry, 1960